Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients
-
Published:2024-07-29
Issue:9
Volume:43
Page:2889-2898
-
ISSN:0770-3198
-
Container-title:Clinical Rheumatology
-
language:en
-
Short-container-title:Clin Rheumatol
Author:
Azoulay Levi-Dan, Frapard Thomas, Larcher Romaric, Pène Frédéric, Argaud Laurent, Mayaux Julien, Jamme Matthieu, Coudroy Remi, Mathian Alexis, Gibelin Aude, Azoulay Elie, Tandjaoui-Lambiotte Yacine, Dargent Auguste, Beloncle François-Michel, Raphalen Jean-Herlé, Bréchot Nicolas, de Prost Nicolas, Devaquet Jérôme, Contou Damien, Gaugain Samuel, Trouiller Pierre, Grangé Steven, Ledochowski Stanislas, Lemarie Jérémie, Faguer Stanislas, Degos Vincent, Frere Corinne, Quentric Paul, Moyon Quentin, Luyt Charles-Edouard, Combes Alain, Amoura Zahir, Pineton de Chambrun MarcORCID
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Garcia D, Erkan D (2018) Diagnosis and management of the antiphospholipid syndrome. N Engl J Med 378:2010–2021. https://doi.org/10.1056/NEJMra1705454 2. Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Demoule A, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle F-M, Raphalen J-H, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Combes A, Luyt C-E, Amoura Z (2019) CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission. J Autoimmun 103:102292. https://doi.org/10.1016/j.jaut.2019.06.003 3. Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle F-M, Raphalen J-H, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Luyt C-E, Combes A, Amoura Z (2020) In-hospital mortality-associated factors in patients with thrombotic antiphospholipid syndrome requiring ICU admission. Chest 157:1158–1166. https://doi.org/10.1016/j.chest.2019.11.010 4. Cervera R, Piette J-C, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RHWM, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris J-C, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Boffa M-C, Hughes GRV, Ingelmo M (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients: clinical and immunologic manifestations of APS. Arthritis Rheum 46:1019–1027. https://doi.org/10.1002/art.10187 5. Rodríguez-Pintó I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G, Cervera R (2016) Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the international CAPS registry. Autoimmun Rev 15:1120–1124. https://doi.org/10.1016/j.autrev.2016.09.010
|
|